New study tests pharmacist coaching to boost RA drug adherence

NCT ID NCT05413759

Recruiting now Disease control Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether extra support from a pharmacist—starting in the hospital and continuing after discharge—can help people with rheumatoid arthritis take their disease-modifying medications more consistently. Two hundred participants will either receive this pharmaceutical care or usual follow-up. The main goal is to see if the intervention improves medication adherence after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pharmaceutical care (medication reconciliation and motivational interviews)
What this could lead to: If successful, this approach could help more rheumatoid arthritis patients take their medications as prescribed, potentially improving disease control and quality of life.
What could go wrong: This is a relatively small, early-stage study focused on adherence, not a new treatment. The intervention may not significantly change behavior or health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATOID ARTHRITIS

Contacts and locations

Locations

Service de rhumatologie et pathologie osseuse - Hôpital Edouard Herriot
RECRUITING

Lyon, 69003, France
Service de rhumatologie, Centre Hospitalier Lyon Sud, Groupement Hospitalier Sud, Hospices Civils de Lyon
NOT_YET_RECRUITING

Pierre-Bénite, Lyon, 69495, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.